Characteristics | COV-POS | COV-NEG | HCO |
---|---|---|---|
Number of participants | 20 | 16 | 12 |
Sex: Male | 10 (50%) | 8 (50%) | 4 (44%) |
Age (Median) | 56 (IQR: 53–64) | 69 (IQR: (53–80) | 44 (IQR: 29–46) |
Days since symptom debut* | 8 (IQR: 3.75–10) | 2 (IQR: 1–4.75) | 0 |
Clinical diagnosis | |||
Infectious etiology | |||
Viral | 20 (100%) | 5 (31.3%) | 0 (0%) |
Bacterial | 0 (0%) | 4 (25%) | 0 (0%) |
Unknown | 0 (0%) | 5 (31,3%) | 0 (0%) |
Non-infectious respiratory symptoms | 0 (0%) | 2 (12.5%) | 0 (0%) |
Comorbidities | |||
Asthma | 1 (5%) | 0 (0%) | 0 (0%) |
COPD | 3 (15%) | 1 (6.25%) | 0 (0%) |
Obesity | 10 (50%) | 4 (25%) | 1 (8.3%) |
Symptoms | |||
Coughing | 14 (70%) | 8 (50%) | 0 (0%) |
Fever | 11 (55%) | 6 (38%) | 0 (0%) |
Throat pain | 2 (10%) | 3 (19%) | 0 (0%) |
Stomach pain | 4 (20%) | 4 (25%) | 0 (0%) |
Dyspnea | 19 (95%) | 9 (56%) | 0 (0%) |
Myalgia | 3 (15%) | 1 (6%) | 0 (0%) |
Hospitalized | 20 (100%) | 7 (44%) | 0 (0%) |